Expands law to target manufacturing/distributing illicit drug-making equipment destined for US.
Mrs. Moody (party and state not specified in bill text) introduced the bill.
Introduced in the Senate, referred to committee.
The 'Preventing Rogue Equipment for Synthetic Substances Act' (S. 4446), or 'PRESS Act', aims to make it a federal crime to manufacture or distribute equipment like pill presses if there's intent or knowledge that it will be used to create controlled substances unlawfully imported into the United States. It also sets out new, potentially longer prison sentences for these offenses and directs the U.S. Sentencing Commission to update its guidelines. The bill was introduced by Mrs. Moody (party and state not specified in the bill text) and is currently awaiting review in a Senate committee.
Introduced Apr 30, 2026
This bill was introduced in the Senate on April 30, 2026, and has been referred to the Senate Committee on the Judiciary. For the bill to become law, it must first be approved by this committee, then passed by the full Senate. After that, it would need to pass the House of Representatives and finally be signed into law by the President.
If this bill becomes law, it would create new federal offenses for individuals who manufacture or distribute specific types of equipment, such as pill presses or encapsulating machines, when they know or intend for that equipment to be used to make illegal drugs imported into the U.S. Those convicted of these crimes could face significant prison terms, with maximums ranging up to 15 years in certain aggravated cases. The U.S. Sentencing Commission would also be required to revise federal sentencing guidelines to incorporate these new offenses and penalties.
Supporters Say
Supporters would likely argue this bill strengthens legal tools to combat the flow of illicit drug manufacturing equipment into the United States, aiming to protect public safety.
Critics Say
The bill text does not detail specific criticisms, but some might question the bill's overall effectiveness or the practical challenges of enforcing its expanded jurisdiction.
The bill text itself does not include arguments from supporters or critics. However, advocates for this bill would likely highlight its potential to disrupt the supply chain of dangerous counterfeit drugs, particularly those containing highly potent substances like fentanyl, by targeting the equipment used in their production. Conversely, some might raise general concerns about the complexities of enforcing U.S. laws extraterritorially or whether such measures are the most effective approach to addressing the drug crisis.